Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-06-08

FDA Approved: EVEROLIMUS — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved Hikma Pharmaceuticals USA Inc.'s generic Everolimus under an Original Application, enabling the sale of a generic version of the immunosuppressant/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Everolimus (everolimus)

Snippet

ORIG AP for EVEROLIMUS (EVEROLIMUS)